Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclaris Therapts
(NQ:
ACRS
)
2.090
+0.280 (+15.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,257,488
Open
1.810
Bid (Size)
2.080 (2)
Ask (Size)
2.150 (5)
Prev. Close
1.810
Today's Range
1.770 - 2.130
52wk Range
0.5902 - 5.705
Shares Outstanding
71,344,557
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via
Benzinga
Performance
YTD
+99.05%
+99.05%
1 Month
+78.63%
+78.63%
3 Month
+63.28%
+63.28%
6 Month
+53.68%
+53.68%
1 Year
-58.78%
-58.78%
More News
Read More
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
July 23, 2024
Via
Benzinga
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
July 11, 2024
Via
MarketBeat
Aclaris Therapeutics: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Aclaris Therapeutics
January 11, 2024
Via
Benzinga
Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying
July 08, 2024
Via
Benzinga
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 24, 2024
Via
Benzinga
ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
Via
FinancialNewsMedia
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
March 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
Via
Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Via
Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
January 16, 2024
Via
Benzinga
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Via
Benzinga
Crude Oil Falls 1%; Amarin Shares Spike Higher
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial
January 10, 2024
Via
Benzinga
Dow Surges 100 Points; PriceSmart Earnings Top Views
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 10, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.